InspireMD (NASDAQ: NSPR) reported Q2 EPS of ($0.26), $0.05 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $1.78 million versus the consensus estimate of $1.92 million.

For earnings history and earnings-related data on InspireMD (NSPR) click here.